Related Experiment Video
Updated: Mar 13, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
A transdisciplinary framework for managing metabolic dysfunction associated steatotic liver disease
Sania Kouser1, Sanketh V Sharma1, Arun Bhanu1
1Ayurveda Biology and Holistic Nutrition, The University of Transdisciplinary Health Sciences and Technology (TDU), Bengaluru, Karnataka, India.
Metabolic dysfunction-associated steatotic liver disease (MASLD) requires new approaches beyond conventional drugs. This transdisciplinary framework integrates traditional Ayurvedic medicine with modern biomedicine for holistic health restoration and wellness.
Area of Science:
- Integrative medicine
- Metabolic disorders
- Traditional Indian medicine
Background:
- Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health concern.
- Conventional pharmacological approaches face challenges due to MASLD's complex etiology and comorbidities.
- The limitations of the "lock-and-key" drug paradigm necessitate innovative management strategies.
Purpose of the Study:
- To propose a transdisciplinary framework for MASLD management.
- To integrate holistic principles of traditional medicine with molecular precision of modern biomedicine.
- To explore Ayurveda as a model for this integrated approach.
Main Methods:
- Development of a unified, biologically plausible transdisciplinary approach.
- Incorporation of dual-diagnostic workflows and an integrative decision interface.
- Implementation of a stage-adaptive management algorithm for MASLD care.
Main Results:
- The framework emphasizes personalized strategies combining nutrition, lifestyle, and drug interventions.
- It leverages the molecular precision of biomedicine and systemic effects of phytochemicals.
- The model shifts focus from disease treatment to health restoration and long-term wellness.
Conclusions:
- This transdisciplinary model offers a comprehensive and patient-centered solution for MASLD.
- It addresses the complexity of MASLD by integrating diverse therapeutic modalities.
- Challenges and scopes for this innovative framework are highlighted for future research and application.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

